(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 6164.82 | 6913.72 | -10.83 | 6164.82 | 6913.72 | -10.83 | 21441.41 | 20022.66 | 7.09 |
| Other Income | 46.24 | 37.45 | 23.47 | 46.24 | 37.45 | 23.47 | 121.11 | 72.26 | 67.60 |
| PBIDT | 705.08 | 877.77 | -19.67 | 705.08 | 877.77 | -19.67 | 2337.04 | 2260.56 | 3.38 |
| Interest | 46.50 | 36.50 | 27.40 | 46.50 | 36.50 | 27.40 | 165.12 | 67.23 | 145.60 |
| PBDT | 658.58 | 841.27 | -21.72 | 658.58 | 841.27 | -21.72 | 2171.92 | 2193.33 | -0.98 |
| Depreciation | 95.93 | 72.78 | 31.81 | 95.93 | 72.78 | 31.81 | 352.16 | 290.48 | 21.23 |
| PBT | 562.65 | 768.49 | -26.78 | 562.65 | 768.49 | -26.78 | 1819.76 | 1902.85 | -4.37 |
| TAX | 144.34 | 195.48 | -26.16 | 144.34 | 195.48 | -26.16 | 461.60 | 505.19 | -8.63 |
| Deferred Tax | -13.08 | 11.53 | -213.44 | -13.08 | 11.53 | -213.44 | 39.18 | -48.72 | -180.42 |
| PAT | 418.31 | 573.01 | -27.00 | 418.31 | 573.01 | -27.00 | 1358.16 | 1397.66 | -2.83 |
| Equity | 290.98 | 290.98 | 0.00 | 290.98 | 290.98 | 0.00 | 290.98 | 290.98 | 0.00 |
| PBIDTM(%) | 11.44 | 12.70 | -9.92 | 11.44 | 12.70 | -9.92 | 10.90 | 11.29 | -3.46 |
| Company Name | CMP |
|---|---|
| UPL | 568.00 |
| PI Industries | 2486.00 |
| Bayer CropScience | 4085.95 |
| Sharda Cropchem | 791.75 |
| Sumitomo Chem. India | 541.25 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: